MBX Biosciences, Inc. is a clinical stage biopharmaceutical company pioneering investigational Precision Endocrine Peptides (PEPs™). PEPs are designed to overcome key limitations of native peptide therapeutics to deliver superior pharmacologic properties. MBX is advancing a pipeline of PEP candidates to address the unmet needs of people with endocrine disorders. The company’s lead product candidate, MBX 2109 for the treatment of hypoparathyroidism, is currently in a Phase 1 clinical trial. Members of MBX’s leadership team have collaborated over several decades on the discovery, development, and commercialization of highly successful endocrine therapeutics including Forteo® and Humalog®. The company is supported by leading life science investors including Frazier Life Sciences, New Enterprise Associates and OrbiMed.
Location: United States, Indiana, Carmel
Employees: 11-50
Total raised: $149.6M
Founded date: 2019
Investors 4
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | OrbiMed | orbimed.co... |
| - | Norwest Ve... | nvp.com |
| - | Frazier Li... | frazierls.... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 14.11.2022 | Series B | $115M | - | orbimed.co... |
| 28.07.2020 | Series A | $34.6M | - | finsmes.co... |
Mentions in press and media 12
| Date | Title | Description | Source |
| 21.11.2022 | Digital health news, funding round up in the prior week; Nov... | DispatchHealth raised $330M; Sondermind bought True Brain; Elizabeth Holmes gets 11 years in prison ... | vator.tv/n... |
| 14.11.2022 | MBX Biosciences Closes $115M Series B | CARMEL, IN, MBX Biosciences, a clinical stage biopharmaceutical company, announced the closing of ... | vcnewsdail... |
| 14.11.2022 | MBX Biosciences closes on $115M in drug-development funding | - | ibj.com/ar... |
| 14.11.2022 | MBX Biosciences Closes $115 Million Series B Financing to Ad... | - | globenewsw... |
| 14.11.2022 | MBX Biosciences Closes $115 Million Series B Financing to Ad... | - | orbimed.co... |
| 26.04.2022 | Slone Partners Places Richard B. Bartram as Chief Financial ... | “Rick Bartram is a tremendously talented and respected business leader with an outstanding track rec... | prweb.com/... |
| 28.07.2020 | MBX Biosciences Closes $34.6M Series A Financing | MBX Biosciences, a Carmel, Ind.-based drug discovery company focused in rare endocrine diseases, clo... | finsmes.co... |
| 28.07.2020 | MBX Biosciences gets $34.6M | Drug discovery startup MBX Biosciences has landed $34.6 million in a Series A led by Frazier Healthc... | pitchbook.... |
| 27.07.2020 | MBX Biosciences Closes $34.6 Million Series A Financing in R... | - | orbimed.co... |
| 27.07.2020 | MBX Biosciences Closes $34.6M Series A | CARMEL, IN, MBX Biosciences announced the closing of a $34.6 million Series A financing led by Fra... | vcnewsdail... |
Show more